THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Johnson & Johnson and Sail Biomedicines announced strategic agreements to advance Sail’s in vivo CAR-T platform for immune-mediated diseases, with an option for Johnson & Johnson to acquire Sail.

Current status
Official collaboration
Known availability
The official source confirms the collaboration; timing details remain under review.
Place
New Brunswick, United States
Source checked
September 16, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.